Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Category: science communication
Knight Cancer signal achievements of 2022
People at the Knight Cancer Institute accomplished a lot in 2022. Through innovative, collaborative research and education, the institute delivers cancer prevention, detection, and care — one...
Knight Cancer signal achievements of 2021
In a year that was anything but normal, the OHSU Knight Cancer Institute’s people stepped up and continued to do great things. From basic research, to patient care, to impact in the community, the...
Cancer researchers are reinventing clinical trials: Get the story at Knight School
The survival rate for all cancers combined more than doubled since the 1960s, a testament to the power of clinical trials that test new treatments in volunteers. But big challenges loom. Pictured...
Dive into the science of precision cancer medicine at Knight School
Targeted therapy drugs have transformed the outlook for people diagnosed with one form of blood cancer, chronic myeloid leukemia. A disease with a three- to five-year life expectancy became, for...
Big milepost for a Knight Cancer scientist: 1000 papers
Gordon Mills, M.D., Ph.D., was fresh out of college when his first journal article appeared in 1976. He’s been quite busy since then, with a publication count that just hit quadruple...
Introducing Knight School
A new series of science talks produced by the OHSU Knight Cancer Institute debuts this month in Portland. Researchers, clinicians and patients are going on stage to present interconnected stories of...
Cancer Translated’s top blog posts of the year
Developing exercise as "medicine" for cancer. Questioning guidelines for off-label use of cancer drugs. Using a common pain reliever to reduce breast cancer risks. These were some of the most...
What magnitude of benefit is meaningful to cancer patients?
Oncologists often use the phrase "clinically meaningful benefit" to describe the effect of an experimental treatment. But is the benefit meaningful for patients? A new paper suggests that benefit...
Clearing the quandary of cancer early detection
For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...
When evidence contradicts entrenched medical practices
Medical reversal is the phenomenon when a medical practice falls out of favor not by being surpassed, but when researchers discover that it didn't really work all along. “I think the lesson of...